Halberd Corp. (HALB)
0.0013
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Halberd Shareholders Equity (Quarterly) : -0.8741M for Jan. 31, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2026 | -0.8741M |
| October 31, 2025 | -0.8497M |
| July 31, 2025 | -0.9131M |
| April 30, 2025 | -0.9122M |
| January 31, 2025 | -0.9036M |
| October 31, 2024 | -0.9006M |
| July 31, 2024 | -0.9264M |
| April 30, 2024 | -0.8857M |
| January 31, 2024 | -0.8731M |
| October 31, 2023 | -0.898M |
| July 31, 2023 | -0.9264M |
| April 30, 2023 | -0.9239M |
| January 31, 2023 | -0.9389M |
| October 31, 2022 | -0.8803M |
| July 31, 2022 | -0.7279M |
| April 30, 2022 | -0.6161M |
| January 31, 2022 | -8.285M |
| October 31, 2021 | -0.4227M |
| July 31, 2021 | -0.4854M |
| April 30, 2021 | -0.1582M |
| January 31, 2021 | -0.5017M |
| October 31, 2020 | -0.5407M |
| July 31, 2020 | -0.285M |
| April 30, 2020 | -0.5125M |
| January 31, 2020 | -0.5062M |
| Date | Value |
|---|---|
| October 31, 2019 | -0.5021M |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | |
| October 31, 2018 | |
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 | -0.6224M |
| April 30, 2017 | -0.623M |
| January 31, 2017 | -0.6603M |
| October 31, 2016 | -0.635M |
| July 31, 2016 | -0.6291M |
| April 30, 2016 | -0.6244M |
| January 31, 2016 | -0.6514M |
| October 31, 2015 | -0.6595M |
| July 31, 2015 | -0.6631M |
| April 30, 2015 | -0.6615M |
| January 31, 2015 | -0.6631M |
| October 31, 2014 | -0.9017M |
| July 31, 2014 | -0.7146M |
| April 30, 2014 | -0.6824M |
| January 31, 2014 | -0.3793M |
| October 31, 2013 | -0.3008M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Altimmune, Inc. | 474.21M |
| AnaptysBio, Inc. | 10.58M |
| Aligos Therapeutics, Inc. | 31.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0041M |
| Total Liabilities (Quarterly) | 0.8783M |
| Debt to Equity Ratio | -0.1716 |
| Current Ratio | 0.0025 |